346 related articles for article (PubMed ID: 26272305)
1. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale.
Castellucci LA; Shaw J; van der Salm K; Erkens P; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2015 Oct; 136(4):727-31. PubMed ID: 26272305
[TBL] [Abstract][Full Text] [Related]
2. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
3. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
Leung TS; Law EH
Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
[TBL] [Abstract][Full Text] [Related]
4. Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.
Rossi AP; Facchinetti R; Ferrari E; Nori N; Sant S; Masciocchi E; Zoico E; Fantin F; Mazzali G; Zamboni M
J Thromb Thrombolysis; 2018 Aug; 46(2):139-144. PubMed ID: 29761426
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy.
Patel SI; Cherington C; Scherber R; Barr K; McLemore R; Morisky DE; Cha S; Mookadam F; Shamoun F
J Am Osteopath Assoc; 2017 Jan; 117(1):7-15. PubMed ID: 28055097
[TBL] [Abstract][Full Text] [Related]
6. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
[TBL] [Abstract][Full Text] [Related]
7. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
[TBL] [Abstract][Full Text] [Related]
8. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.
Bartoli-Abdou JK; Patel JP; Crawshaw J; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
Thromb Res; 2018 Feb; 162():62-68. PubMed ID: 29306122
[TBL] [Abstract][Full Text] [Related]
9. Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011-2014.
Schuh T; Reichardt B; Finsterer J; Stöllberger C
J Thromb Thrombolysis; 2016 Oct; 42(3):447-51. PubMed ID: 27221106
[TBL] [Abstract][Full Text] [Related]
10. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
[TBL] [Abstract][Full Text] [Related]
11. The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.
Rolls CA; Obamiro KO; Chalmers L; Bereznicki LRE
Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28869793
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anticoagulation selection for acute venous thromboembolism.
Badreldin H; Nichols H; Rimsans J; Carter D
J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
[TBL] [Abstract][Full Text] [Related]
13. Is it reasonable to use a lower DOAC dose in some patients with VTE? NO.
Dentali F; Fantoni C
Intern Emerg Med; 2017 Aug; 12(5):565-567. PubMed ID: 28656545
[TBL] [Abstract][Full Text] [Related]
14. A Real-World Cost-Effectiveness Analysis of Rivaroxaban versus Vitamin K Antagonists for the Treatment of Symptomatic Venous Thromboembolism: Lessons from the REMOTEV Registry.
Kepka S; Cordeanu EM; Zarca K; Frantz AS; Ohlmann P; Andres E; Bilbault P; Durand-Zaleski I; Stephan D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676804
[No Abstract] [Full Text] [Related]
15. Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study.
Bartoli-Abdou JK; Patel JP; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
Thromb Res; 2021 Dec; 208():162-169. PubMed ID: 34801919
[TBL] [Abstract][Full Text] [Related]
16. Current challenges and future prospects in oral anticoagulant therapy.
Czuprynska J; Patel JP; Arya R
Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.
Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE
Int J Clin Pract; 2018 Mar; 72(3):e13072. PubMed ID: 29457323
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants.
Weitz JI; Jaffer IH; Fredenburgh JC
F1000Res; 2017; 6():985. PubMed ID: 28713563
[TBL] [Abstract][Full Text] [Related]
19. Persistence to direct oral anticoagulants for acute venous thromboembolism.
Dronkers CEA; Lijfering WM; Teichert M; van der Meer FJM; Klok FA; Cannegieter SC; Huisman MV
Thromb Res; 2018 Jul; 167():135-141. PubMed ID: 29843087
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants.
Bavalia R; Middeldorp S; Weisser G; Espinola-Klein C
Thromb Haemost; 2020 Jun; 120(6):899-911. PubMed ID: 32492723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
